Richard Reynolds, PhD will receive a two-year investigator-initiated research grant from Pfizer. The study is entitled “Evaluating genetic heterogeneity of HLA B and HLA DRB1 risk alleles with rheumatoid arthritis in African Americans: Is classical allelic and amino acid sequence level genetic risk conditional on European or African ancestry?”